Sökning: WFRF:(Vishram Julie K. K.)
> (2015) >
Blood pressure vari...
Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage : a LIFE substudy
-
- Vishram, Julie K.K. (författare)
- Research Centre for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark; Department of Internal Medicine, Næstved Hospital, Næstved, Denmark
-
- Dahlöf, Björn, 1953 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
-
- Devereux, Richard B. (författare)
- Weill Medical College of Cornell University, NY, New York, United States
-
visa fler...
-
- Ibsen, Hans (författare)
- Division of Cardiology, Holbæk University Hospital, Holbæk, Denmark
-
- Kjeldsen, Sverre E. (författare)
- Ullevaal University Hospital, Oslo, Norway
-
- Lindholm, Lars H. (författare)
- Umeå University Hopsital, Umeå, Sweden
-
- Mancia, Giuseppe (författare)
- University of Milano-Bicocca, IRCCS Istituto Auxologico Italiano, Milan, Italy
-
- Okin, Peter M. (författare)
- Weill Medical College of Cornell University, NY, New York, United States
-
- Rothwell, Peter M. (författare)
- Stroke Prevention Research Unit, University Department of Clinical Neurology, John Radcliffe Hospital, West Wing, Headington, Oxford, United Kingdom
-
- Wachtell, Kristian (författare)
- Department of Internal Medicine, Glostrup Hospital, University of Copenhagen, Glostrup, Denmark
-
- Olsen, Michael H. (författare)
- Cardiovascular and Metabolic Preventive Clinic, Department of Endocrinology, Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark; Hypertension in Africa Research Team (HART), North-West University, Mahikeng, South Africa
-
visa färre...
-
(creator_code:org_t)
- Lippincott Williams & Wilkins, 2015
- 2015
- Engelska.
-
Ingår i: Journal of Hypertension. - : Lippincott Williams & Wilkins. - 0263-6352 .- 1473-5598. ; 33:12, s. 2422-2430
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
https://gup.ub.gu.se...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Assessment of antihypertensive treatment is normally based on the mean value of a number of blood pressure (BP) measurements. However, it is uncertain whether high in-treatment visit-to-visit BP variability may be harmful in hypertensive patients with left ventricular hypertrophy (LVH).Methods: In 8505 patients randomized to losartan vs. atenolol-based treatment in the LIFE study, we tested whether BP variability assessed as SD and range for BP6-24months measured at 6, 12, 18 and 24 months of treatment was associated with target organ damage (TOD) defined by LVH on ECG and urine albumin/creatinine ratio at 24 months, and predicted the composite endpoint (CEP) of cardiovascular death, nonfatal myocardial infarction (MI) or stroke occurring after 24 months (CEP=630 events).Results: In multiple regression models adjusted for mean BP6-24months and treatment allocation, neither high BP6-24months SD nor wide range were related to TOD at 24 months, except for a weak association between Sokolow-Lyon voltage and DBP6-24months SD and range (both b=0.04, P<0.01). Independently of mean BP6-24months, treatment allocation, TOD and baseline characteristics in Cox regression models, CEP after 24 months was associated with DBP6-24months SD [hazard ratio per 1mmHg increase1.04, 95% confidence interval (95% CI) 1.01-1.06, P=0.005], range (hazard ratio 1.02, 95% CI 1.01-1.03, P=0.004), SBP6-24months SD (hazard ratio 1.01, 95% CI 0.99-1.02, P=0.07) and range (hazard ratio 1.006, 95% CI 1.001-1.01, P=0.04). Adjusted for the same factors, stroke was associated with DBP6-24months SD (hazard ratio 1.06, 95% CI 1.02-1.10, P=0.001), range (hazard ratio 1.03, 95% CI 1.01-1.04, P=0.001), SBP6-24months SD (hazard ratio 1.02, 95% CI 1.002-1.04, P=0.04) and range (hazard ratio 1.008, 95% CI 1.001-1.02, P=0.05), but MI was not.Conclusion: In LIFE patients, higher in-treatment BP6-24months variability was independently of mean BP6-24months associated with later CEP and stroke, but not with MI or TOD after 24 months.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Allmänmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- General Practice (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- blood pressure variability
- cardiovascular risk
- epidemiology
- target organ damage
- blood pressure variability
- cardiovascular risk
- epidemiology
- target organ damage
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Vishram, Julie K ...
-
Dahlöf, Björn, 1 ...
-
Devereux, Richar ...
-
Ibsen, Hans
-
Kjeldsen, Sverre ...
-
Lindholm, Lars H ...
-
visa fler...
-
Mancia, Giuseppe
-
Okin, Peter M.
-
Rothwell, Peter ...
-
Wachtell, Kristi ...
-
Olsen, Michael H ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Allmänmedicin
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Journal of Hyper ...
- Av lärosätet
-
Umeå universitet
-
Göteborgs universitet